Heart Hospital of New Mexico completes 200 VIVO procedures for Catheter Precision.

Catheter Precision, a medical device company, announced that Heart Hospital of New Mexico has completed 200 ventricular ablation procedures using its VIVO system. The hospital is the first customer to reach this milestone. VIVO is designed to help physicians, and the Heart Hospital team has fully embraced the technology. Catheter Precision's CEO, David Jenkins, congratulated the hospital on this achievement.

Catheter Precision, Inc. (NYSE: VTAK), a leading medical device company focused on cardiac electrophysiology, announced that the Heart Hospital of New Mexico has completed 200 ventricular ablation procedures using its VIVO system. This marks a significant milestone for the hospital and Catheter Precision, as the Heart Hospital is the first customer to reach this achievement [1].

The Heart Hospital of New Mexico, part of the Lovelace Health system, is New Mexico's only hospital dedicated exclusively to cardiovascular care. The hospital's physician team has fully embraced the VIVO technology, using it to identify the origin of ventricular arrhythmias pre-procedure, streamline workflow, and reduce procedure time. The hospital has also published data and facilitated educational initiatives for other physicians regarding the VIVO technology [1].

Catheter Precision's CEO, David Jenkins, congratulated the Heart Hospital on this achievement, stating, "We are excited to congratulate the Heart Hospital of New Mexico on celebrating their 200th procedure utilizing VIVO. VIVO is a tool that is designed to help physicians, and as one of the first users of VIVO, the physician team has fully embraced the technology. They have published their data and welcomed physicians for educational purposes, and their partnership and support of the VIVO product line is invaluable. We look forward to their continued use and seeing what other milestone achievements they accomplish!" [1].

VIVO, a non-invasive 3D imaging system, has received marketing clearance from the U.S. FDA and has the CE Mark. It is designed to help physicians by enabling them to identify the origin of ventricular arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time [1].

Catheter Precision is an innovative U.S.-based medical device company focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products [1].

References:
[1] https://finance.yahoo.com/news/milestone-achievement-hospital-using-catheter-120000259.html
[2] https://www.stocktitan.net/news/VTAK/milestone-achievement-for-hospital-using-catheter-precision-s-vivo-fj20fou69tty.html